Patenia R - Search Results

1

Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo.

Sergeeva A, He H, Ruisaard K, St John L, Alatrash G, Clise-Dwyer K, Li D, Patenia R, Hong R, Sukhumalchandra P, You MJ, Gagea M, Ma Q, Molldrem JJ. Sergeeva A, et al. Among authors: patenia r. Leukemia. 2016 Jul;30(7):1475-84. doi: 10.1038/leu.2016.57. Epub 2016 Mar 8. Leukemia. 2016. PMID: 27055866 Free PMC article.

2

Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma.

Alatrash G, Perakis AA, Kerros C, Peters HL, Sukhumalchandra P, Zhang M, Jakher H, Zope M, Patenia R, Sergeeva A, Yi S, Young KH, Philips AV, Cernosek AM, Garber HR, Qiao N, Weng J, St John LS, Lu S, Clise-Dwyer K, Mittendorf EA, Ma Q, Molldrem JJ. Alatrash G, et al. Among authors: patenia r. Clin Cancer Res. 2018 Jul 15;24(14):3386-3396. doi: 10.1158/1078-0432.CCR-17-2626. Epub 2018 Apr 16. Clin Cancer Res. 2018. PMID: 29661776

3

Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.

Alatrash G, Mittendorf EA, Sergeeva A, Sukhumalchandra P, Qiao N, Zhang M, St John LS, Ruisaard K, Haugen CE, Al-Atrache Z, Jakher H, Philips AV, Ding X, Chen JQ, Wu Y, Patenia RS, Bernatchez C, Vence LM, Radvanyi LG, Hwu P, Clise-Dwyer K, Ma Q, Lu S, Molldrem JJ. Alatrash G, et al. Among authors: patenia rs. J Immunol. 2012 Dec 1;189(11):5476-84. doi: 10.4049/jimmunol.1201221. Epub 2012 Oct 26. J Immunol. 2012. PMID: 23105141 Free PMC article.

4

Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.

Ma Q, Li D, Nurieva R, Patenia R, Bassett R, Cao W, Alekseev AM, He H, Molldrem JJ, Kroll MH, Champlin RE, Sale GE, Afshar-Kharghan V. Ma Q, et al. Among authors: patenia r. Biol Blood Marrow Transplant. 2012 Aug;18(8):1174-81. doi: 10.1016/j.bbmt.2012.05.014. Epub 2012 Jun 1. Biol Blood Marrow Transplant. 2012. PMID: 22664751 Free PMC article.

5

Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLs.

Li D, Li Y, Hernandez JA, Patenia R, Kim TK, Khalili J, Dougherty MC, Hanley PJ, Bollard CM, Komanduri KV, Hwu P, Champlin RE, Radvanyi LG, Molldrem JJ, Ma Q. Li D, et al. Among authors: patenia r. J Immunother. 2010 Nov-Dec;33(9):975-82. doi: 10.1097/CJI.0b013e3181fb0486. J Immunother. 2010. PMID: 20948439 Free PMC article.

6

Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD.

Ma Q, Li D, Carreño R, Patenia R, Tsai KY, Xydes-Smith M, Alousi AM, Champlin RE, Sale GE, Afshar-Kharghan V. Ma Q, et al. Among authors: patenia r. Bone Marrow Transplant. 2014 Jul;49(7):972-6. doi: 10.1038/bmt.2014.75. Epub 2014 Apr 28. Bone Marrow Transplant. 2014. PMID: 24777193 Free PMC article.

7

Development of a cell surface reacting human monoclonal antibody recognizing ovarian and certain other malignancies.

Freedman RS, Ioannides CG, Tomasovic B, Patenia R, Zhang HZ, Liang JC, Edwards CL. Freedman RS, et al. Among authors: patenia r. Hybridoma. 1991 Feb;10(1):21-33. doi: 10.1089/hyb.1991.10.21. Hybridoma. 1991. PMID: 2032733

8

T-cell functions in ovarian cancer patients treated with viral oncolysates: I. Increased helper activity to immunoglobulins production.

Ioannides CG, Platsoucas CD, Patenia R, Kim YP, Bowen JM, Morris M, Edwards C, Wharton JT, Freedman RS. Ioannides CG, et al. Among authors: patenia r. Anticancer Res. 1990 May-Jun;10(3):645-53. Anticancer Res. 1990. PMID: 2142392

9

HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.

Kooi S, Zhang HZ, Patenia R, Edwards CL, Platsoucas CD, Freedman RS. Kooi S, et al. Among authors: patenia r. Cell Immunol. 1996 Dec 15;174(2):116-28. doi: 10.1006/cimm.1996.0301. Cell Immunol. 1996. PMID: 8954611

10

Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin.

Apte SM, Vadhan-Raj S, Cohen L, Bassett RL, Gordon IO, Levenback CF, Ramirez PT, Gallardo ST, Patenia RS, Garcia ME, Iyer RB, Freedman RS. Apte SM, et al. J Transl Med. 2006 Apr 7;4:16. doi: 10.1186/1479-5876-4-16. J Transl Med. 2006. PMID: 16603073 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters